Related references
Note: Only part of the references are listed.Discovery and development of small molecule modulators targeting glutamine metabolism
Lei Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Model Informed Dose Optimization of Dichloroacetate for the Treatment of Congenital Lactic Acidosis in Children
Naveen Mangal et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers
Janeta Popovici-Muller et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
Nicotinamide Adenine Dinucleotide Biosynthesis Promotes Liver Regeneration
Sarmistha Mukherjee et al.
HEPATOLOGY (2017)
PTENβ is an alternatively translated isoform of PTEN that regulates rDNA transcription
Hui Liang et al.
NATURE COMMUNICATIONS (2017)
AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations
Katharine Yen et al.
CANCER DISCOVERY (2017)
Phloretin increases the anti-tumor efficacy of intratumorally delivered heat-shock protein 70 kDa (HSP70) in a murine model of melanoma
Sergey V. Abkin et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Phloretin exhibits an anticancer effect and enhances the anticancer ability of cisplatin on non-small cell lung cancer cell lines by regulating expression of apoptotic pathways and matrix metalloproteinases
Lijie Ma et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine
Lili Guo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Inhibitor Discovery for the Human GLUT1 from Homology Modeling and Virtual Screening
Peter Man-Un Ung et al.
ACS CHEMICAL BIOLOGY (2016)
Identification of novel GLUT inhibitors
Holger Siebeneicher et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
The Emerging Hallmarks of Cancer Metabolism
Natalya N. Pavlova et al.
CELL METABOLISM (2016)
Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY-876
Holger Siebeneicher et al.
CHEMMEDCHEM (2016)
A novel hypoxia-selective epigenetic agent RRx-001 triggers apoptosis and overcomes drug resistance in multiple myeloma cells
D. S. Das et al.
LEUKEMIA (2016)
GLUT, SGLT, and SWEET: Structural and mechanistic investigations of the glucose transporters
Dong Deng et al.
PROTEIN SCIENCE (2016)
Lipid metabolic reprogramming in cancer cells
S. Beloribi-Djefaflia et al.
ONCOGENESIS (2016)
PFK15, a Small Molecule Inhibitor of PFKFB3, Induces Cell Cycle Arrest, Apoptosis and Inhibits Invasion in Gastric Cancer
Wei Zhu et al.
PLOS ONE (2016)
Lipid Droplets: A Key Cellular Organelle Associated with Cancer Cell Survival under Normoxia and Hypoxia
Shiro Koizume et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Salicylketoximes That Target Glucose Transporter1 Restrict Energy Supply to Lung Cancer Cells
Carlotta Granchi et al.
CHEMMEDCHEM (2015)
Molecular Pathways: Fatty Acid Synthase
Suzanne F. Jones et al.
CLINICAL CANCER RESEARCH (2015)
MYC and metabolism on the path to cancer
Annie L. Hsieh et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2015)
Cholesteryl Ester Accumulation Induced by PTEN Loss and PI3K/AKT Activation Underlies Human Prostate Cancer Aggressiveness
Shuhua Yue et al.
CELL METABOLISM (2014)
Hexokinase 2 regulates G1/S checkpoint through CDK2 in cancer-associated fibroblasts
Jun-wei Hu et al.
CELLULAR SIGNALLING (2014)
Glutaminase regulation in cancer cells: a druggable chain of events
William P. Katt et al.
DRUG DISCOVERY TODAY (2014)
Inhibition of lactate dehydrogenase activity as an approach to cancer therapy
Luigi Fiume et al.
FUTURE MEDICINAL CHEMISTRY (2014)
Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer
Matt I. Gross et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Crystal structure of the human glucose transporter GLUT1
Dong Deng et al.
NATURE (2014)
Estrogen receptors alpha (ERα) and beta (ERβ): Subtype-selective ligands and clinical potential
Ilaria Paterni et al.
STEROIDS (2014)
Hexokinase 2 overexpression promotes the proliferation and survival of laryngeal squamous cell carcinoma
Jian Chen et al.
TUMOR BIOLOGY (2014)
Hexokinase 2-Mediated Warburg Effect Is Required for PTEN- and p53-Deficiency-Driven Prostate Cancer Growth
Lei Wang et al.
CELL REPORTS (2014)
Hypoxia inducible factor pathway inhibitors as anticancer therapeutics
Sarah K. Burroughs et al.
FUTURE MEDICINAL CHEMISTRY (2013)
Small-molecule inhibitors of human LDH5
Carlotta Granchi et al.
FUTURE MEDICINAL CHEMISTRY (2013)
mTOR regulates phagosome and entotic vacuole fission
Matej Krajcovic et al.
MOLECULAR BIOLOGY OF THE CELL (2013)
Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells
Cosimo Commisso et al.
NATURE (2013)
Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids
Jurre J. Kamphorst et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Dysfunctional oxidative phosphorylation makes malignant melanoma cells addicted to glycolysis driven by the V600EBRAF oncogene
Arnaldur Hall et al.
ONCOTARGET (2013)
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
Haoqiang Ying et al.
CELL (2012)
K-rasG12V transformation leads to mitochondrial dysfunction and a metabolic switch from oxidative phosphorylation to glycolysis
Yumin Hu et al.
CELL RESEARCH (2012)
c-Myc and Cancer Metabolism
Donald M. Miller et al.
CLINICAL CANCER RESEARCH (2012)
Hypoxia-inducible factors and their roles in energy metabolism
Nobuhito Goda et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2012)
被撤回的出版物: Development of a Novel Class of Glucose Transporter Inhibitors (Retracted article. See vol. 61, pg. 5056, 2018)
Dasheng Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
A Small-Molecule Inhibitor of Glucose Transporter 1 Downregulates Glycolysis, Induces Cell-Cycle Arrest, and Inhibits Cancer Cell Growth In Vitro and In Vivo
Yi Liu et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Crystal structure of a bacterial homologue of glucose transporters GLUT1-4
Linfeng Sun et al.
NATURE (2012)
Alterations of metabolic genes and metabolites in cancer
Eric K. Oermann et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2012)
Otto Warburg's contributions to current concepts of cancer metabolism
Willem H. Koppenol et al.
NATURE REVIEWS CANCER (2011)
Novel inhibitors of basal glucose transport as potential anticancer agents
Weihe Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
Anne Le et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes
Arnold J. Levine et al.
SCIENCE (2010)
Blinded by the Light: The Growing Complexity of p53
Karen H. Vousden et al.
CELL (2009)
Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment
Zachary T. Schafer et al.
NATURE (2009)
Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells
Jihye Yun et al.
SCIENCE (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Flavonoids: modulators of brain function?
Jeremy P. E. Spencer
BRITISH JOURNAL OF NUTRITION (2008)
Lipid bodies are reservoirs of cyclooxygenase-2 and sites of prostaglandin-E2 synthesis in colon cancer cells
Maria T. Accioly et al.
CANCER RESEARCH (2008)
The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications
Amancio Carnero et al.
CURRENT CANCER DRUG TARGETS (2008)
dLKR/SDH regulates hormone-mediated histone arginine methylation and transcription of cell death genes
Dimitrios Cakouros et al.
JOURNAL OF CELL BIOLOGY (2008)
Pharmacological exploitation of the peroxisome proliferator-activated receptor γ agonist ciglitazone to develop a novel class of androgen receptor-ablative agents
Jian Yang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction
David R. Wise et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Hypoxia-inducible factor I and dysregulated c-myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1
Jung-Whan Kim et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES)
Mary M. Robinson et al.
BIOCHEMICAL JOURNAL (2007)
Regulation of tumor pH and the role of carbonic anhydrase 9
Pawel Swietach et al.
CANCER AND METASTASIS REVIEWS (2007)
Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking
Heather L. Wiernan et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Essential role for nuclear PTEN in maintaining chromosomal integrity
Wen Hong Shen et al.
CELL (2007)
Clinicopathological significance and linkage of the distribution of HIF-1 alpha and GLUT-1 in human primary colorectal cancer
Andrzej Wincewicz et al.
PATHOLOGY & ONCOLOGY RESEARCH (2007)
Ras transformation requires metabolic control by 6-phosphofructo-2-kinase
S. Telang et al.
ONCOGENE (2006)
Glycolysis inhibition for anticancer treatment
H. Pelicano et al.
ONCOGENE (2006)
The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysis
R van Wijk et al.
BLOOD (2005)
Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer
ML Macheda et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
TT232, a novel signal transduction inhibitory compound in the therapy of cancer and inflammatory diseases
O Szokoloczi et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2005)
Naringenin inhibits glucose uptake in MCF-7 breast cancer cells: a mechanism for impaired cellular proliferation
AW Harmon et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
High frequency of mutations of the PIK3CA gene in human cancers
Y Samuels et al.
SCIENCE (2004)
The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression
F Schwartzenberg-Bar-Yoseph et al.
CANCER RESEARCH (2004)
The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress
RJ Shaw et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Neuronal apoptotic bodies: phagocytosis and degradation by primary microglial cells
A Stolzing et al.
FASEB JOURNAL (2004)
The PIK3CA gene is mutated with high frequency in human breast cancers
KE Bachman et al.
CANCER BIOLOGY & THERAPY (2004)
Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak
N Majewski et al.
MOLECULAR CELL (2004)
Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP
YH Ko et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
The inhibitory effects of flavonoids and antiestrogens on the Glut1 glucose transporter in human erythrocytes
HJ Martin et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2003)
Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer
IPM Tomlinson et al.
NATURE GENETICS (2002)
Salicylaldoxime moiety as a phenolic A-ring substitute in estrogen receptor ligands
F Minutolo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase
K Gottlob et al.
GENES & DEVELOPMENT (2001)
Inhibition of glucose and dehydroascorbic acid uptakes by resveratrol in human transformed myelocytic cells
JB Park
JOURNAL OF NATURAL PRODUCTS (2001)
Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study
M De Lena et al.
EUROPEAN JOURNAL OF CANCER (2001)
Accelerated publication -: Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc
RC Osthus et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma
BE Baysal et al.
SCIENCE (2000)
Share Paper
